Premier Anti-Aging Co., Ltd.

4934

JP3833690005

Personal Products

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-25 am EDT			5-day change	1st Jan Change
799 ^JPY	+0.38%		+7.68%	-20.97%

Mar. 15	Premier Anti-Aging Clarifies Discrepancies Between H1 FY2024 Actual Results, Forecast	MT
Mar. 14	Premier Anti-Aging Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2024	CI

Novera Inc. announced that it has received funding from Premier Anti-Aging Co., Ltd.

July 14, 2021

Novera Inc. announced that it has received funding from Premier Anti-Aging Co., Ltd. on July 15, 2021.

Latest news about Premier Anti-Aging Co., Ltd.

Premier Anti-Aging Clarifies Discrepancies Between H1 FY2024 Actual Results, Forecast	Mar. 14	MT
Premier Anti-Aging Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2024	Mar. 14	CI
Premier Anti-Aging Trims Losses in Fiscal Q1	Dec. 15	MT
Premier Anti-Aging Co Finalises Merger of Premier Wellness Science	Nov. 03	MT
Premier Anti-Aging Co., Ltd. Provides Consolidated Earning Guidance for the Six Months Ending January 31, 2024 and Full Year Ending July 31, 2024	23-09-14	CI
Premier Anti-Aging Co., Ltd. Announces Head Office Relocation	23-09-14	CI
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2023	23-06-14	CI
Premier Anti-Aging Swings to Loss in Fiscal H1	23-03-15	MT
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2023	23-03-14	CI
Premier Anti-Aging Co., Ltd. completed the acquisition of Venex Co., Ltd from Taichi Nakamura and other shareholders.	23-01-30	CI
Premier Anti-Aging to Buy Japanese Recovery Wear Manufacturer; Shares Jump 4%	23-01-18	MT
Premier Anti-Aging Co., Ltd. agreed to acquire Venex Co., Ltd from Taichi Nakamura and other shareholders.	23-01-16	CI
Premier Anti-Aging Falls from Black in Fiscal Q1 on Weak Sales of Flagship Product	22-12-14	MT
Premier Anti-Aging Co., Ltd. Provides Consolidated Earning Guidance for the Six Months Ending January 31, 2023 and Full Year Ending July 31, 2023	22-12-14	CI
Premier Anti-Aging Co., Ltd.(TSE:4934) dropped from S&P Global BMI Index	22-09-19	CI
Premier Anti-Aging's Attributable Profit Falls 49% in FY22	22-09-14	MT
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ended January 31, 2023 and Fiscal Year Ended July 31, 2023	22-09-13	CI
Premier Anti-Aging Unit to Debut New Skin Care Brand	22-09-07	MT
Premier Wellness Science Co., Ltd. to Launch a New Brand "Reinca"	22-09-06	CI
SQUIZ Co., Ltd. announced that it has received funding from Premier Anti-Aging Co., Ltd.	22-07-25	CI
Premier Anti-Aging Unit to Launch New Cannabidiol Product Brand	22-07-07	MT
Premier Anti-Aging Co., Ltd.’s Consolidated Subsidiary Premier Wellness Sciences Co., Ltd. Announces the Launch of Its New Brand "Ko" with CBD	22-07-05	CI
Premier Anti-Aging Co., Ltd. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending July 31, 2022	22-06-13	CI
Premier Anti-Aging Unit Signs License Agreement with Lexaria for Drug Delivery System	22-06-06	MT
Novera Inc. announced that it has received funding from Premier Anti-Aging Co., Ltd.	21-07-14	CI

Chart Premier Anti-Aging Co., Ltd.

Duration

Period

More charts

Premier Antiaging Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of cosmetics. The Company is involved in the plan, development and sale of cosmetics and health foods. The Company is involved in the provision of information and consulting service on anti-aging, beauty and health. The company is also engaged in the management of beauty clinics and beauty research, as well as market research, collection and analysis of various types of information. The Company Mainly provides DUO and CANADEL brand series. The products are sold through three channels including mail order, wholesale sales and the others.

Sector

Personal Products

Calendar

2024-06-09 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Premier Anti-Aging Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

799 JPY

Average target price

760 JPY

Spread / Average Target

-4.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
PREMIER ANTI-AGING CO., LTD.	-20.97%	44.76M
KAO CORPORATION	+10.47%	19.18B
GALDERMA GROUP AG	0.00%	17.31B
SHISEIDO COMPANY, LIMITED	-0.82%	11B
COTY INC.	-7.53%	10.47B
AMOREPACIFIC CORPORATION	+0.76%	6.48B
PROYA COSMETICS CO.,LTD.	+10.78%	6.04B
NATURA &CO HOLDING S.A.	-1.84%	4.4B
INTER PARFUMS, INC.	-16.31%	4.18B
INTERPARFUMS	-3.97%	3.8B

Cosmetics & Perfumes

Premier Anti-Aging Co., Ltd.

Equities

4934

JP3833690005

Personal Products

Novera Inc. announced that it has received funding from Premier Anti-Aging Co., Ltd.

Latest news about Premier Anti-Aging Co., Ltd.

Chart Premier Anti-Aging Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Premier Anti-Aging Co., Ltd.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Cosmetics & Perfumes